Details
Stereochemistry | ACHIRAL |
Molecular Formula | C9H10O2 |
Molecular Weight | 150.1745 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(=O)C1=CC=C(O)C=C1
InChI
InChIKey=RARSHUDCJQSEFJ-UHFFFAOYSA-N
InChI=1S/C9H10O2/c1-2-9(11)7-3-5-8(10)6-4-7/h3-6,10H,2H2,1H3
Molecular Formula | C9H10O2 |
Molecular Weight | 150.1745 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://pubs.acs.org/doi/abs/10.1021/jo50014a002Curator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/14880602
Sources: http://pubs.acs.org/doi/abs/10.1021/jo50014a002
Curator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/14880602
Paroxypropione (brand names Frenantol, Frenormon, Hypophenon, Paroxon, Possipione, Profenone is a synthetic, non-steroidal estrogen that has been used medically as an antigonadotropin in Spain and Italy. Paroxypropione was first synthesized in 1902. Its antigonadotropic properties were discovered in 1951 and it entered clinical use shortly thereafter. Paroxypropione is a product from the oxidative splitting of stilbestrol, with a low degree of estrogenicity, has been found a valuable drug for checking the growth of lung metastases secondary to certain malignant tumors such as chorionepitheliomas or nephrobiastomas. As the drug possesses relatively low affinity for the estrogen receptor and must be given at high dosages to achieve significant estrogenic and antigonadotropic action.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL4234 Sources: http://www.ncbi.nlm.nih.gov/pubmed/16797984 |
150.56 µM [IC50] | ||
Target ID: CHEMBL2044 Sources: http://www.ncbi.nlm.nih.gov/pubmed/16290145 |
176.0 µM [IC50] | ||
Target ID: CHEMBL1911 Sources: http://www.ncbi.nlm.nih.gov/pubmed/16290145 |
293.0 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Frenantol Approved UseIndications: pituitary hyperactivity |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Synthesis of N-[4-[1-ethyl-2-(2,4-diaminofuro[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid as an antifolate. | 2002 Apr 25 |
|
Anaerobic biodegradation of 4-alkylphenols in a paddy soil microcosm supplemented with nitrate. | 2007 Aug |
|
Minor secondary metabolic products from the stem bark of Plumeria rubra Linn. displaying antimicrobial activities. | 2010 Apr |
|
Chemical composition, antibacterial and antioxidant activity of the essential oil of Bupleurum longiradiatum. | 2010 Jul |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/16797984
Paroxypropione inhibits 17b-HSD3 with IC50 150.56 uM
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 14:58:13 GMT 2023
by
admin
on
Fri Dec 15 14:58:13 GMT 2023
|
Record UNII |
X9952001TG
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C547
Created by
admin on Fri Dec 15 14:58:13 GMT 2023 , Edited by admin on Fri Dec 15 14:58:13 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000082799
Created by
admin on Fri Dec 15 14:58:13 GMT 2023 , Edited by admin on Fri Dec 15 14:58:13 GMT 2023
|
PRIMARY | |||
|
SUB09632MIG
Created by
admin on Fri Dec 15 14:58:13 GMT 2023 , Edited by admin on Fri Dec 15 14:58:13 GMT 2023
|
PRIMARY | |||
|
2069
Created by
admin on Fri Dec 15 14:58:13 GMT 2023 , Edited by admin on Fri Dec 15 14:58:13 GMT 2023
|
PRIMARY | |||
|
m8419
Created by
admin on Fri Dec 15 14:58:13 GMT 2023 , Edited by admin on Fri Dec 15 14:58:13 GMT 2023
|
PRIMARY | Merck Index | ||
|
133070
Created by
admin on Fri Dec 15 14:58:13 GMT 2023 , Edited by admin on Fri Dec 15 14:58:13 GMT 2023
|
PRIMARY | RxNorm | ||
|
X9952001TG
Created by
admin on Fri Dec 15 14:58:13 GMT 2023 , Edited by admin on Fri Dec 15 14:58:13 GMT 2023
|
PRIMARY | |||
|
15
Created by
admin on Fri Dec 15 14:58:13 GMT 2023 , Edited by admin on Fri Dec 15 14:58:13 GMT 2023
|
PRIMARY | |||
|
Paroxypropione
Created by
admin on Fri Dec 15 14:58:13 GMT 2023 , Edited by admin on Fri Dec 15 14:58:13 GMT 2023
|
PRIMARY | |||
|
70-70-2
Created by
admin on Fri Dec 15 14:58:13 GMT 2023 , Edited by admin on Fri Dec 15 14:58:13 GMT 2023
|
PRIMARY | |||
|
CHEMBL312311
Created by
admin on Fri Dec 15 14:58:13 GMT 2023 , Edited by admin on Fri Dec 15 14:58:13 GMT 2023
|
PRIMARY | |||
|
DTXSID8023426
Created by
admin on Fri Dec 15 14:58:13 GMT 2023 , Edited by admin on Fri Dec 15 14:58:13 GMT 2023
|
PRIMARY | |||
|
6271
Created by
admin on Fri Dec 15 14:58:13 GMT 2023 , Edited by admin on Fri Dec 15 14:58:13 GMT 2023
|
PRIMARY | |||
|
2834
Created by
admin on Fri Dec 15 14:58:13 GMT 2023 , Edited by admin on Fri Dec 15 14:58:13 GMT 2023
|
PRIMARY | |||
|
200-743-2
Created by
admin on Fri Dec 15 14:58:13 GMT 2023 , Edited by admin on Fri Dec 15 14:58:13 GMT 2023
|
PRIMARY | |||
|
C90867
Created by
admin on Fri Dec 15 14:58:13 GMT 2023 , Edited by admin on Fri Dec 15 14:58:13 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |